"When treatment is more challenging than the disease": A qualitative study of MDR-TB patient retention

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Shringarpure, Kalpita S ^a   Isaakidis, Petros ^b   Sagili, Karuna D ^c   Baxi, R K ^a   Das, Mrinalini ^b   Daftary, Amrita ^d,e,f  

^a Baroda Medical College   (India)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c Union   (India)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; FEMALE; FOLLOW UP; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; LONG TERM CARE; MALE; MEDICATION COMPLIANCE; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PRIVATE PRACTICE; QUALITATIVE RESEARCH; SOCIAL PROBLEM; SOCIAL SUPPORT; STIGMA; THEMATIC ANALYSIS; TRADITIONAL HEALER; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WORK; MIDDLE AGED; PERCEPTION; SOCIAL STIGMA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCEPTION; QUALITATIVE RESEARCH; SOCIAL STIGMA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84962557534     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150849     Document Type: Article

References (32)

1. World Health Organization. Global Tuberculosis Report [Internet]. Available from http://apps.who.int/ iris/bitstream/10665/91355/1/9789241564656-eng.pdf
2. Guidelines for the programmatic management of drug-resistant tuberculosis. 2008Available from: http://apps.who.int/iris/bitstream/10665/43965/1/9789241547581-eng.pdf
3. Sanchez-Padilla E, Marquer C, Kalon S, Qayyum S, Hayrapetyan A, Varaine F, et al. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia : a quantitative and qualitative study. Int J Tuberc Lung Dis 18(2):160-167. doi: 10.5588/ijtld.13.0369 PMID: 24429307
4. Jeon DS, Shin DO, Park SK, Seo JE, Seo HS, Cho YS, et al. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector. J Korean Med Sci [Internet]. 2011 Jan [cited 2014 Sep 5]; 26(1):33-41. Available from:www.ncbi.nlm.nih.gov/ pubmed/21218027 doi: 10.3346/jkms.2011.26.1.33 PMID: 21218027
5. Shringarpure KS, Isaakidis P, Sagili KD, Baxi RK. Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It. PLoS One [Internet]. 2015 Jan [cited 2015 Aug 4]; 10(7):e0132543. Available from: journals.plos.org/plosone/article?id=10.1371/journal.pone. 0132543 doi: 10.1371/journal.pone.0132543 PMID: 26167891
6. Munro S a, Lewin S a, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med [Internet]. 2007 Jul 24 [cited 2014 Sep 19]; 4(7):e238. Available from: journals.plos.org/plosone/article?id=10.1371/journal.pone. 0128541 PMID: 17676945
7. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One [Internet]. 2009 Jan [cited 2013 Oct 3]; 4(9):e6914. Available from: journals.plos.org/plosone/article?id=10.1371/journal.pone.0006914 doi: 10.1371/journal.pone.0006914 PMID: 19742330
8. Government of India. TB INDIA 2014 Revised National TB Control Programme Annual Status Report. 2014. Available from: http://www.tbcindia.nic.in/pdfs/TB%20INDIA%202014.pdf
9. Holtz T, Lancaster J. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001⋯ . Tuberc ⋯ [Internet]. 2006 [cited 2014 Sep 3];10(September 2001):649-55. Available from: http://www.ingentaconnect.com/content/iuatld/ijtld/2006/00000010/ 00000006/art00010
10. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis [Internet]. 2002 Sep; 6(9):780-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12234133 PMID: 12234133
11. Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis [Internet]. Elsevier Ltd; 2009 Mar [cited 2013 Oct 3]; 9(3):153-61. Available from: http://www. ncbi.nlm.nih.gov/pubmed/19246019 doi: 10.1016/S1473-3099(09)70041-6 PMID: 19246019
12. Deshmukh RD, Dhande DJ, Sachdeva KS,Sreenivas A, Kumar AMV, Satyanarayana S, et al. (2015) Patient and Provider Reported Reasons forLost to Follow Up in MDRTB treatment: A QualitativeStudy from a Drug Resistant TB Centre in India.PLoS ONE 10(8): e0135802. doi: 10.1371/journal.pone. 0135802 PMID: 26301748
13. Cavanaugh JS, Kazennyy BY, Nguyen ML, Kiryanova E V, Vitek E, Khorosheva TM, et al. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005. Int J Tuberc Lung Dis [Internet]. 2012 Aug; 16(8):1069-74. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/22691694 doi: 10.5588/ijtld.11.0696 PMID: 22691694
14. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care (2007). 19(6):349-57. DOI: http://dx.doi.org/10.1093/intqhc/mzm042 PMID: 17872937
15. Stirling JA. Thematic networks; an analytic tool for qualitative research.Qual Res. 2001; 1(3): 385-405. doi: 10.1177/146879410100100307
16. Corbin J. M. and Strauss A. (1990). "Grounded theory research: Procedures, canons, and evaluative criteria." Qualitative sociology 13(1): 3-21.
17. Patton M. Q. (2002). Qualitative Research and Evaluation Methods. Thousand Oaks, CA, Sage Publications.
18. Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T, Kielmann K. "I cry every day": experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health [Internet]. 2013 Sep [cited 2013 Sep 16]; 18(9):1128-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 23837468 doi: 10.1111/tmi.12146 PMID: 23837468
19. Furin J, Isaakidis P, Reid AJ, Kielmann K. "I" m fed up ': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV. 2014; 18(April):1479-84. www.ncbi.nlm.nih.gov/ pubmed/25517815
20. Courtwright A, Turner AN. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 125 Suppl 4:34-42. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882973 PMID: 20626191
21. Christodoulou M. The stigma of tuberculosis. Lancet Infect Dis [Internet]. Elsevier Ltd; 2011; 11(9):663-4. Available from: http://dx.doi.org/10.1016/S1473-3099(11)70228-6 PMID: 21977509
22. Sharma R1, Yadav R2, Sharma M3, Saini V4, Koushal V. Quality of life of multi drug resistant tuberculosis patients: a study of north India. Acta Med Iran. 2014; 52(6): 448-53. PMID: 25130152
23. Singla R, Sarin R, Khalid UK, Mathuria K, Singla N, Jaiswal a, et al. Seven-year DOTS-Plus pilot experience in India: results, constraints and issues. Int J Tuberc Lung Dis [Internet]. 2009 Aug; 13(8):976-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19723377 PMID: 19723377
24. Chiang, Centis R, Migliori GB. Invited Review Series :Drug-Resistant tuberculosis: Past, present, future. Respirology. 2010; 15(November 2009):413-32. Available from: www.ncbi.nlm.nih.gov/ pubmed/20337989 doi: 10.1111/j.1440-1843.2010.01738.x PMID: 20337989
25. Zammarchi L, Bartalesi F, Bartoloni A. Tuberculosis in tropical areas and immigrants. Mediterr J Hematol Infect Dis. 2014; 6(1). Available from: www.ncbi.nlm.nih.gov/pubmed/24959340
26. Franke MF, Appleton SC, Bayona J, Arteaga F, Llaro K, Shin SS, et al. Risk Factors and Mortality Associated with Default from Multidrug-Resistant Tuberculosis Treatment. Clin Infect Dis. 2009; 46 (12):1844-51.
27. Toczek a, Cox H, du Cros P, Cooke G, Ford N. Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis [Review article]. Int J Tuberc Lung Dis. 2013; 17 (3):299-307. Available from:www.ncbi.nlm.nih.gov/pubmed/23211716 doi: 10.5588/ijtld.12.0537 PMID: 23211716
28. Baral SC, Aryal Y, Bhattrai R, King R, Newell JN. The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB : mixed method qualitative and pilot intervention studies. 2014; available from: www.biomedcentral.com/1471-2458/14/46 doi: 10.1186/ 1471-2458-14-46 PMID: 24438351
29. Tomás BA, Pell C, Cavanillas AB, Solvas JG, Pool R, Roura M. Tuberculosis in migrant populations. A systematic review of the qualitative literature. PLoS One. 2013; 8(12):1-12.
30. Bell C a, Duncan G, Saini B. Knowledge, attitudes and practices of private sector providers of tuberculosis care: a scoping review. Int J Tuberc Lung Dis [Internet]. 2011 Aug [cited 2014 Sep 24]; 15 (8):1005-17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21669027 doi: 10.5588/ijtld.10.0294 PMID: 21669027
31. Mistry N, Tolani M, Osrin D. Drug-resistant tuberculosis in Mumbai, India: An agenda for operations research. Oper Res Heal care [Internet]. Elsevier Ltd; 2012 Jun [cited 2014 Sep 23]; 1(2-3):45-53. Available from: www.ncbi.nlm.nih.gov/pubmed/24501697
32. Kielmann K, Datye V, Pradhan A,Rangan S. Balancing authority, deference and trust across the publicprivate divide in health care: tuberculosis health visitors in western Maharashtra, India. Glob Public Health. 2014; 9(8):975-92. doi: 10.1080/17441692.2014.941898 Epub 2014 Aug 22. PMID: 25147003